827 related articles for article (PubMed ID: 17625012)
1. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study.
Pavare J; Grope I; Kalnins I; Gardovska D
BMC Infect Dis; 2010 Feb; 10():28. PubMed ID: 20158885
[TBL] [Abstract][Full Text] [Related]
4. Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards.
Ratzinger F; Haslacher H; Perkmann T; Schmetterer KG; Poeppl W; Mitteregger D; Dorffner G; Burgmann H
Eur J Clin Invest; 2015 Aug; 45(8):815-23. PubMed ID: 26046926
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.
Gaïni S; Koldkjaer OG; Pedersen C; Pedersen SS
Crit Care; 2006; 10(2):R53. PubMed ID: 16569262
[TBL] [Abstract][Full Text] [Related]
6. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
[TBL] [Abstract][Full Text] [Related]
7. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
Pavcnik-Arnol M; Hojker S; Derganc M
Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.
Kitanovski L; Jazbec J; Hojker S; Derganc M
Support Care Cancer; 2014 Jan; 22(1):269-77. PubMed ID: 24057110
[TBL] [Abstract][Full Text] [Related]
10. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
[TBL] [Abstract][Full Text] [Related]
12. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
13. Role of combined procalcitonin and lipopolysaccharide-binding protein as prognostic markers of mortality in patients with ventilator-associated pneumonia.
Rumende CM; Mahdi D
Acta Med Indones; 2013 Apr; 45(2):89-93. PubMed ID: 23770787
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis.
Lin S; Huang Z; Wang M; Weng Z; Zeng D; Zhang Y; Zhu Y; Jiang J
J Crit Care; 2015 Aug; 30(4):732-8. PubMed ID: 25891645
[TBL] [Abstract][Full Text] [Related]
15. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin.
Wang H; Yin F; Shen DX; Zhang YJ; Luo YP; Liu CJ; Wang KF; Zhou G; Ye LY; Chen G; Wang XN
J Int Med Res; 2013 Oct; 41(5):1671-81. PubMed ID: 24065454
[TBL] [Abstract][Full Text] [Related]
17. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
Johansson N; Kalin M; Backman-Johansson C; Larsson A; Nilsson K; Hedlund J
Scand J Infect Dis; 2014 Nov; 46(11):787-91. PubMed ID: 25195651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
